4.4 Article

Clinical impact of early reinsertion of a central venous catheter after catheter removal in patients with catheter-related bloodstream infections

期刊

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
卷 42, 期 2, 页码 162-168

出版社

CAMBRIDGE UNIV PRESS
DOI: 10.1017/ice.2020.405

关键词

-

资金

  1. National Research Foundation of Korea grant - Korean government (MSIT) [NRF -2018R1C1B 5043292]

向作者/读者索取更多资源

The study evaluated the clinical impact of early CVC reinsertion in patients with CRBSIs. Results showed a higher risk of persistent CRBSI with early reinsertion, but no significant difference compared to delayed reinsertion. There were also no significant differences in other clinical outcomes among the three groups.
Objective: Early replacement of a new central venous catheter (CVC) may pose a risk of persistent or recurrent infection in patients with a catheter-related bloodstream infection (CRBSI). We evaluated the clinical impact of early CVC reinsertion after catheter removal in patients with CRBSIs. Methods: We conducted a retrospective chart review of adult patients with confirmed CRBSIs in 2 tertiary-care hospitals over a 7-year period. Results: To treat their infections, 316 patients with CRBSIs underwent CVC removal. Among them, 130 (41.1%) underwent early CVC reinsertion (<= 3 days after CVC removal), 39 (12.4%) underwent delayed reinsertion (>3 days), and 147 (46.5%) did not undergo CVC reinsertion. There were no differences in baseline characteristics among the 3 groups, except for nontunneled CVC, presence of septic shock, and reason for CVC reinsertion. The rate of persistent CRBSI in the early CVC reinsertion group (22.3%) was higher than that in the no CVC reinsertion group (7.5%; P = .002) but was similar to that in the delayed CVC reinsertion group (17.9%; P > .99). The other clinical outcomes did not differ among the 3 groups, including rates of 30-day mortality, complicated infection, and recurrence. After controlling for several confounding factors, early CVC reinsertion was not significantly associated with persistent CRBSI (OR, 1.59; P = .35) or 30-day mortality compared with delayed CVC reinsertion (OR, 0.81; P = .68). Conclusions: Early CVC reinsertion in the setting of CRBSI may be safe. Replacement of a new CVC should not be delayed in patients who still require a CVC for ongoing management.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据